SCHEMBL9918941

SCHEMBL9918941

C=CCOc1cc(C)ccc1N=C=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
HPGD P15428 5/20 0.43
CYP3A4 P08684 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
NPC1 O15118 1/20 0.36
KDM4E B2RXH2 4/20 0.36
MAPT P10636 1/20 0.36
TRPA1 O75762 1/20 0.35
TSHR P16473 2/20 0.35
GAA P10253 1/20 0.35
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA9 Q16790 1/20 0.34
KMT2A Q03164 1/20 0.34
PDE4B Q07343 2/20 0.33
PDE4A P27815 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9918952 0.88 HPGD (0.39) ALDH1A1HPGDCYP3A4TDP1NPC1
SCHEMBL10980256 0.84 CYP3A4 (0.42) ALDH1A1HPGDCYP3A4TDP1KDM4E
SCHEMBL28861605 0.81 ALDH1A1 (0.47) ALDH1A1HPGDCYP3A4TDP1KDM4E
SCHEMBL4341836 0.78 HPGD (0.47) ALDH1A1HPGDCYP3A4TDP1NPC1
SCHEMBL9918950 0.77 ALDH1A1 (0.46) ALDH1A1HPGDCYP3A4TDP1NPC1
SCHEMBL9918943 0.77 CYP3A4 (0.54) ALDH1A1HPGDCYP3A4NPC1KDM4E
SCHEMBL5252562 0.76 ALDH1A1 (0.71) ALDH1A1HPGDCYP3A4TDP1KDM4E
SCHEMBL22215851 0.76 KDM4E (0.46) ALDH1A1HPGDTDP1KDM4EMAPT
SCHEMBL27717926 0.75 CYP3A4 (0.42) ALDH1A1HPGDCYP3A4TDP1KDM4E
SCHEMBL9529565 0.75 PPOX (0.39) ALDH1A1HPGDTDP1NPC1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9334236-B2 Lactam-based compounds with a urethane or urea functional group, and uses thereof ISP INVESTMENTS INC. (US) 2016-05-10 US disclosed
US-9334236-B2 Lactam-based compounds with a urethane or urea functional group, and uses thereof ISP INVESTMENTS INC. (US) 2016-05-10 US disclosed
US-20120149861-A1 LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF ISP INVESTMENTS LLC 2012-06-14 US disclosed
US-20120149861-A1 LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF ISP INVESTMENTS LLC 2012-06-14 US disclosed
WO-2011022457-A1 LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF ISP INVESTMENTS INC. (US) 2011-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149861-A1 LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF CUTA, PUF60, PAM ALDH1A1 1456/4885HPGD 3532/4885CYP3A4 2144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.